TNNI3 and type 2 diabetes mellitus: The cutoffs for T2DM patients, computed to maximize the differences in survival prediction between groups, were as follows: sST2; low, < 16.5 ng/mL; high, ≥ 32.0 ng/mL; hs-cTnI; low, < 4.2 ng/L; high, ≥ 7.8 ng/L; NT-proBNP; low, < 89 ng/L; high, ≥ 337 ng/L.